Professor Esther Rodriguez Villegas, Founder, Acurable 12.15.23
Throughout history, technological innovation has played a vital role in improving the efficiency and effectiveness of the provision of patient care. Medical devices, in particular, have helped to make diagnosis, treatment and management of medical conditions easier, safer and, in some cases, quicker and more accessible. As we look ahead to 2024, that progress is set to continue and even accelerate. Here are a few key trends to keep an eye on as we move into the new year.
In 2024, we can expect to see more integration of the Internet of Medical Things into our daily lives. In other words, increased interconnectivity of technologies that have recently emerged which can enable health-relevant real-time monitoring and data collection. This will be especially relevant in the context of chronic conditions, although it could also extend to improved care of those who are more fragile, not just as a consequence of an existing disease.
In this context, we might, for example, see wearable and environmental devices that seamlessly transmit parameters of interest to carers and/or health professionals. This will not just help the latter to make more informed decisions based on more timely and frequent access to a combination of disease-representative biomarkers, but it can also eventually be an invaluable source of information for researchers, unveiling new knowledge about the specific diseases as well as leading to the development of new more effective interventions.
The ease of data collection the Internet of Medical Things will increasingly enable and accelerate advances in novel AI-powered technologies that, looking further into the future, have the potential to completely change the delivery of healthcare.
Furthermore, medical devices are now leading the way in creating a more personalized approach. In 2024, we can expect an increase in the development and adoption of devices that offer solutions based on, for example, individual patients’ unique genetic makeup, lifestyle, health history and state of the disease at a particular period in time.
For instance, genetic testing devices can provide insights into a patient's risk level for certain diseases, allowing healthcare professionals to take preventive measures and offer appropriate care. Data collected from connected drug delivery devices, such as inhalers in the case of asthma, can play an important role in aiding healthcare providers in their care provision, and wearable sensors have the ability to provide a much larger frequent sample—in some cases even in real-time—of physiological parameters that clinicians could potentially start using to better inform individual interventions.
For example, if we were to take the case of epilepsy patients, having a reliable, quantifiable indication of how a patient responds to their treatment could be used to objectively decide on different treatment alternatives as well as dosage.
Also, as the world continues to emerge from the Covid pandemic, telehealth looks set to keep accelerating in 2024. In many cases, doctors’ consultations can be done virtually, and, if needed, technologies can be remotely prescribed for self-administration, enabling diagnostic testing or monitoring that previously could only be done in hospitals or clinics.
This is particularly relevant for those with chronic conditions who may benefit from frequent clinical assessment but struggle to travel to hospital regularly. Remote patient monitoring can not only enhance patient comfort and convenience but also facilitate early intervention when needed, preventing complications and reducing healthcare costs in the long run.
Going beyond wearables, smart implants such as neurostimulators are becoming increasingly sophisticated, offering targeted and personalized treatment options oriented towards the alleviation of symptoms of diseases. These devices can also be programmed based on individual patient responses, which means they can provide a level of precision that traditional interventions may lack.
In conclusion, the medical device landscape in 2024 promises to continue to be dynamic and transformative. New developments will allow the medical devices industry to deliver more patient-centric solutions, resulting in better outcomes and greater access to the healthcare we all deserve.
Professor Esther Rodriguez Villegas is the founder of MedTech startup Acurable and creator of the first-of-its-kind wearable medical device designed for sleep apnea detection.
In 2024, we can expect to see more integration of the Internet of Medical Things into our daily lives. In other words, increased interconnectivity of technologies that have recently emerged which can enable health-relevant real-time monitoring and data collection. This will be especially relevant in the context of chronic conditions, although it could also extend to improved care of those who are more fragile, not just as a consequence of an existing disease.
In this context, we might, for example, see wearable and environmental devices that seamlessly transmit parameters of interest to carers and/or health professionals. This will not just help the latter to make more informed decisions based on more timely and frequent access to a combination of disease-representative biomarkers, but it can also eventually be an invaluable source of information for researchers, unveiling new knowledge about the specific diseases as well as leading to the development of new more effective interventions.
The ease of data collection the Internet of Medical Things will increasingly enable and accelerate advances in novel AI-powered technologies that, looking further into the future, have the potential to completely change the delivery of healthcare.
Furthermore, medical devices are now leading the way in creating a more personalized approach. In 2024, we can expect an increase in the development and adoption of devices that offer solutions based on, for example, individual patients’ unique genetic makeup, lifestyle, health history and state of the disease at a particular period in time.
For instance, genetic testing devices can provide insights into a patient's risk level for certain diseases, allowing healthcare professionals to take preventive measures and offer appropriate care. Data collected from connected drug delivery devices, such as inhalers in the case of asthma, can play an important role in aiding healthcare providers in their care provision, and wearable sensors have the ability to provide a much larger frequent sample—in some cases even in real-time—of physiological parameters that clinicians could potentially start using to better inform individual interventions.
For example, if we were to take the case of epilepsy patients, having a reliable, quantifiable indication of how a patient responds to their treatment could be used to objectively decide on different treatment alternatives as well as dosage.
Also, as the world continues to emerge from the Covid pandemic, telehealth looks set to keep accelerating in 2024. In many cases, doctors’ consultations can be done virtually, and, if needed, technologies can be remotely prescribed for self-administration, enabling diagnostic testing or monitoring that previously could only be done in hospitals or clinics.
This is particularly relevant for those with chronic conditions who may benefit from frequent clinical assessment but struggle to travel to hospital regularly. Remote patient monitoring can not only enhance patient comfort and convenience but also facilitate early intervention when needed, preventing complications and reducing healthcare costs in the long run.
Going beyond wearables, smart implants such as neurostimulators are becoming increasingly sophisticated, offering targeted and personalized treatment options oriented towards the alleviation of symptoms of diseases. These devices can also be programmed based on individual patient responses, which means they can provide a level of precision that traditional interventions may lack.
In conclusion, the medical device landscape in 2024 promises to continue to be dynamic and transformative. New developments will allow the medical devices industry to deliver more patient-centric solutions, resulting in better outcomes and greater access to the healthcare we all deserve.
Professor Esther Rodriguez Villegas is the founder of MedTech startup Acurable and creator of the first-of-its-kind wearable medical device designed for sleep apnea detection.